Tripping Up: AIDS, Pharmaceuticals and Intellectual Property in South Africa

Trading Women’s Health and Rights?: Trade Liberalization and Reproductive Health in Developing Economies

Volumn , Issue , 2008, Pages 212-234

  Maharaj, Pranitha ^a   Roberts, Benjamin ^b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b Southern African Regional Poverty Network   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85192133943     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (59)

1. Albertyn, C. (2003) ‘Contesting Democracy: HIV/AIDS and the Achievement of Gender Equality in South Africa’, Feminist Studies, vol. 29, no. 3: 595–615.
2. Annas, G. (2003) ‘The Right to Health and the Nevirapine Case in South Africa’, New England Journal of Medicine, vol. 348: 750–4.
3. Baker, B. (2002) African AIDS: Impacts of Globalisation, Pharmaceutical Apartheid, and Treatment Activism, Northeastern University School of Law, draft manuscript.
4. Barnett, T., and A. Whiteside (2002) Aids in The Twenty-First Century: Disease and Globalisation, Basingstoke: Palgrave.
5. Berger, J. (2001) Tripping over Patents: AIDS, Access to Treatment and the Manufacturing of Scarcity, Thesis, Faculty of Law, University of Toronto, Toronto.
6. Bloom, D., and River Path Associates (2000) ‘Something to be Done: Treating HIV/AIDS’, Science, vol. 288: 2171–3.
7. Bond, P. (1999) ‘Globalization, Pharmaceutical Pricing and South African Health Policy: Managing Confrontation with U.S. Firms and Politicians’, International Journal of Health Services, vol. 29, no. 4: 765–92.
8. Braveman, P., and S. Gruskin (2003) ‘Poverty, Equity, Human rights and Health’, Bulletin of the World Health Organization, vol. 81, no. 7: 539–45.
9. Budlender, D. (2004) Why Should We Care about Unpaid Care Work? Harare: UNIFEM.
10. Buch, E. (2001) ‘The Health Sector Strategic Framework: A Review’, South African Health Review 2000, Durban: Health Systems Trust.
11. Commission on Intellectual Property Rights (CIPR) (2002) Integrating Intellectual Property Rights and Development Policy, Report of the Commission on Intellectual Property Rights, London.
12. Constitution of the Republic of South Africa (adopted 8 May 1996, amended 11 October 1996).
13. Correa, C. (2000) Intellectual Property Rights, the WTO, and Developing Countries, New York: Zed Books.
14. Cullet, P. (2003) ‘Patents and Medicines: The Relationship between TRIPS and the Human Right to Health’, International Affairs, vol. 79, no. 1: 139–60.
15. Declaration of Commitment on HIV/AIDS (2001) ‘Global Crisis-Global Action’, United Nations, General Assembly, 26th Special Session. Available online, Joint United Nations Programme on HIV/AIDS (UNAIDS).
16. Department for International Development (DFID) (2004) Increasing Access to Essential Medicines in the Developing World: UK Government Policy and Plans, London: DFID.
17. Doherty, T., and M. Colvin (2004) ‘HIV/AIDS’, South African Health Review 2003–2004, Durban: Health Systems Trust.
18. Doyal, L. (2002) ‘Putting Gender into Health and Globalization Debates: New Perspectives and Old Challenges’, Third World Quarterly, vol. 23, no. 2: 233–50.
19. Du Guerny, J., and E. Sjoberg (1993) ‘Interrelationship between Gender Relations and HIV/AIDS Epidemic: Some Possible Consideration for Policies and Programmes’, AIDS, vol. 7: 1027–34.
20. Ford, N. (2003) ‘Patents, Access to Medicines and the Role of Nongovernmental Organisations’, Journal of Generic Medicines, vol. 1, no. 2: 137–45.
21. Foreman, M. (2002) Patents, Pills and Public Health: Can TRIPS Deliver?, London: The Panos Institute.
22. Fosse, F. (2002) ‘Controversy over TRIPS and the Public Health Agreement’, International Gender and Trade Network Monthly Bulletin, vol. 2, no. 10 (December).
23. Gray, A., and T. Matsebula (2001) ‘Drug Pricing’, South African Health Review 2000, Durban: Health Systems Trust.
24. Gupta, D. (2003) ‘The Neoliberal Case for South African Patent Defiance’, Law, Social Justice & Global Development Journal, no. 2.
25. Hankins, C. (2000) ‘Preventing Mother-to-Child Transmission of HIV in Developing Countries: Recent Developments and Ethical Implications’, Reproductive Health Matters, vol. 8: 87–92.
26. Harrison, A., N. Xaba, P. Kunene, and N. Ntuli (2001) ‘Understanding Young Women’s Risk for HIV/AIDS: Adolescent Sexuality and Vulnerability in Rural KwaZulu/Natal’, Society in Transition, vol. 32, no. 1: 79–82.
27. Hassan, F. (2004) ‘Slow Road to Drugs Roll-Out’, Mail and Guardian, July.
28. Heywood, M. (2001) Debunking ‘Conglomo-Talk’: A Case Study of the Amicus Curiaeas, an Instrument for Advocacy, Investigation and Mobilisation, Johannesburg, Treatment Action Campaign.
29. Ijumba, P., C. Poole, G. George, and A. Gray (2004) ‘Access to Antiretroviral Therapy’, South African Health Review 2003/2004, Durban: Health Systems Trust.
30. International Intellectual Property Institute (IIPI) (2000) Patent Protection and Access to HIV/AIDS Pharmaceuticals in Sub-Saharan Africa, Washington, DC: The International Intellectual Property Institute.
31. Joint Health and Treasury Task Team (2004) Examining Treatment Options to Supplement Comprehensive Care for HIV/AIDS in the Public Health Sector, August 2003.
32. Kasper, T. (2001) South Africa’s Victory for the Developing World, Geneva: Médecins Sans Frontières.
33. Kober, K., and W. Van Damme (2004) ‘Scaling Up Access to Antiretroviral Treatment in Southern Africa: Who will do the Job?’, The Lancet, vol. 364: 103–7.
34. Loewenson, R., and A. Whiteside (2001) ‘HIV/AIDS Implications for Poverty Reduction’, background paper prepared for the United Nations Development Programme for the UN General Assembly Special Session on HIV/AIDS, Policy Paper.
35. Mankahlana, P. (2000) ‘Buying Anti-AIDS Drugs Benefit the Rich’, Business Day, Johannesburg.
36. Martinson, N., B. Radebe, M. Mntambo, and A. Violari (2003) ‘Antiretrovirals’, South African Health Review 2002, Durban: Health Systems Trust.
37. Matowe, L. (2004) ‘Access to Essential Drugs in Developing Countries: A Lost Battle?’, American Journal of Health-Systems Pharmacy, vol. 718: 718–21.
38. McCray, T.M. (2004) ‘An Issue of Culture: The Effects of Daily Activities on Prenatal Care Utilisation Patterns in Rural South Africa’, Social Science & Medicine, vol. 59: 1843–55.
39. Médecins Sans Frontières (2004) Untangling the Web of Price Reductions: A Pricing Guide for the Purchase of ARVs for Developing Countries, 6th edn, Geneva: Médecins Sans Frontières.
40. Nelson Mandela (NM) and HSRC (2002) South African National HIV Prevalence, Behavioural Risks and Mass Media Household Survey 2002, Cape Town: Human Science Research Council.
41. Padarath, A., C. Chamberlain et al. (2003) ‘Health Personnel in Southern Africa: Confronting Maldistribution and Brain Drain’, Equinet Discussion Paper Series 3, Durban: Health Systems Trust.
42. Parliamentary Office of Science and Technology (POST) (2001) Access to Medicines in the Developing World, Postnote 160, London.
43. Petchesky, R. (2003) ‘HIV/AIDS and the Human Right to Health: On a Collision Course with Global Capitalism’, Global Prescriptions: Gendering Health and Human Rights, New York: Zed Books.
44. Pharmaceutical Research and Manufacturers of America (PhRMA) (2004) Pharmaceutical Industry Profile 2004, Washington, DC: PhRMA.
45. Rao Gupta, G. (2000) ‘Gender, Sexuality, and HIV/AIDS: The What, the Why, and the How’, Plenary address at the 12th International AIDS Conference, Durban, South Africa, 12 July.
46. Schneider, H. (2002). ‘On the Fault Line: The Politics of AIDS policy in Contemporary South Africa’, African Studies, vol. 61, no. 1: 145–67.
47. Selis, S. (2003) ‘Study Calculated Outlay of Pharmaceutical Marketing’, Stanford Report, May.
48. Shisana, O., E. Hall, K.R. Maluleke, D.J. Stoker, C. Schwabe, M. Colvin, J. Chauveau, C. Botha, T. Gumede, H. Fomundam, N. Shaikh, T. Rehle, E. Udjo, and D. Gisselquist (2003) The Impact of HIV/AIDS on the Health Sector, National Survey of Health Personnel, Ambulatory and Hospitalised Patients and Health Facilities, Cape Town: Human Science Research Council.
49. Sivard, R. (1995) Women: A World Survey, Washington, DC: World Priorities.
50. Stewart, R., A. Padarath, and L. Bamford (2004) Providing Antiretroviral Treatment in Southern Africa, Durban: Health Systems Trust.
51. T’Hoen, E. (2003) ‘TRIPS, Pharmaceutical Patents and Access to Essential Medicines: Seattle, Doha and Beyond’, in J. Moatti, B. Coriat and Y. Souteyrandet et al. (eds), Economics of AIDS and Access to HIV/AIDS Care in Developing Countries, Issues and Challenges, Paris: Agence Nationale de Recherches sur le Sida: 39-67.
52. UNAIDS (2000) Report on the Global HIV/AIDS Epidemic, Geneva: UNAIDS.
53. UNAIDS (2004) 2004 Report on the Global AIDS Epidemic, Geneva: UNAIDS.
54. Weissman, R. (1999) ‘AIDS and Developing Countries: Democratizing Access to Essential Medicines’, Foreign Policy in Focus, vol. 4, no. 23: 1–4.
55. Williams, M. (2001) ‘The TRIPS and Public Health Debate: An Overview’, International Gender and Trade Network (IGTN).
56. Wood, E., P. Braitstein, J.S. Montaner, M.T. Schechter, M.W. Tyndall, M.V. O’Shaughnessy, and R.S. Hogg (2000) ‘Extent to which Low-Level Use of Antiretroviral Treatment could Curb the AIDS epidemic in Sub-Saharan Africa’, The Lancet, vol. 355: 2095–100.
57. Wood, F., F. Maforah, and R. Jewkes (1998) ‘ “He Forced me to Love him”: Putting Violence on Adolescent Sexual Health Agendas’, Social Science and Medicine, vol. 47, no. 2: 233–42.
58. Woolard, I., and M. Leibbrandt (2001) ‘Measuring Poverty in South Africa’, in H. Bhorat, M. Leobbrandt, M. Maziya, S. Van der Berg and I. Woolard (eds), Fighting Poverty: Labour Markets and Inequality in South Africa, Cape Town: UCT Press.
59. World Trade Organization (1994) TRIPS Agreement, Geneva: World Trade Organization.